Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

Sarepta Therapeutics, Inc. · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
duchenne-muscular-dystrophypediatric
muscular dystrophy, duchenne, duchenne muscular dystrophy, gene-delivery, dmd, ambulatory, pediatric, north star ambulatory assessment (nsaa), percent dystrophin positive fibers (pdpf), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 869619
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.